반응식
[CH2:1]([O:3][C:4](=[O:22])[CH2:5][C:6]1[CH:11]=[CH:10][CH:9]=[C:8]([O:12][C:13]2[CH:18]=[CH:17][C:16]([Br:19])=[CH:15][C:14]=2[CH2:20]Br)[CH:7]=1)[CH3:2].[NH:23]1[CH2:27][CH2:26][CH2:25][C:24]1=[O:28].[H-].[Na+]>O1CCOCC1>[CH2:1]([O:3][C:4](=[O:22])[CH2:5][C:6]1[CH:11]=[CH:10][CH:9]=[C:8]([O:12][C:13]2[CH:18]=[CH:17][C:16]([Br:19])=[CH:15][C:14]=2[CH2:20][N:23]2[CH2:27][CH2:26][CH2:25][C:24]2=[O:28])[CH:7]=1)[CH3:2]참가 물질
5
실험 절차
[3-(4-Bromo-2-bromomethyl-phenoxy)-phenyl]-acetic acid ethyl ester (0.15 g, 0.35 mmol) and 2-pyrrolidinone (0.05 g, 0.53 mmol) were combined in 1,4-dioxane (10 mL). Sodium hydride (60% in mineral oil; 0.03 g, 0.7 mmol) was added, and the reaction was stirred at room temperature for 2 hours to give the title compound, which was used as a crude solution in the hydrolysis step.
출처 및 근거
- ORD 기록
- ord-036d42e1c7a54062941b388336509174
- 출처 데이터셋
- uspto-grants-2012_08
- 특허 번호
- US08242145B2
연결된 노트
불러오는 중…